(Q36380990)

13 August 2017

1 reference

title

Endogenous production of nitric oxide synthase inhibitors (English)

1 reference

13 August 2017

3

Patrick Vallance

1 reference

13 August 2017

Shelagh Anthony

1

1 reference

13 August 2017

James Leiper

series ordinal

2

1 reference

13 August 2017

publication date

1 July 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10 Suppl 1

1 reference

13 August 2017

page(s)

S3-9

1 reference

Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Isolation and partial characterization of methylated arginines from the encephalitogenic basic protein of myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Retinol influences contractile function and exerts an anti-proliferative effect on vascular smooth muscle cells through an endothelium-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Identification and mapping of a novel human gene, HRMT1L1, homologous to the rat protein arginine N-methyltransferase 1 (PRMT1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Regulation of transcription by a protein methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Human PAD4 regulates histone arginine methylation levels via demethylimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

The arginine-nitric oxide pathway in thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM595OA

10.1191/1358863X05VM595OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference